X

Trial Profile

Phase 2 Study to Investigate the Efficacy, Safety, and Tolerability of Six Weeks Treatment With V565 in Subjects With Active Crohn's Disease

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 24 Dec 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs V 565 (Primary)
Indications Crohn's disease
Focus Proof of concept; Therapeutic Use
Acronyms HarbOR
Sponsors VHsquared

Most Recent Events

07 Sep 2019 Status changed from recruiting to completed.
29 Aug 2019 This trial has been completed in Netherlands. According to European Clinical Trials Database.
22 May 2019 This trial was completed in Slovakia (end date: 2019-03-08), according to European Clinical Trials Database.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com